Solid Biosciences LLC
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,124 | $0 |
Gross Profit | -386 | -407 | -488 | -405 |
EBITDA | -41,693 | -38,807 | -42,034 | -32,238 |
EBIT | -42,079 | -39,214 | -42,522 | -32,643 |
Net Income | -39,480 | -39,282 | -42,597 | -32,725 |
Net Change In Cash | 0 | 0 | 3,124 | 0 |
Free Cash Flow | -37,789 | -31,976 | -29,849 | -23,723 |
Cash | 138,933 | 210,629 | 80,235 | 64,394 |
Basic Shares | 94,140 | 66,341 | 40,817 | 41,443 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $8,094 | $13,620 |
Gross Profit | -2,455 | -2,581 | 5,686 | 10,656 |
EBITDA | -121,902 | -93,434 | -96,866 | -69,290 |
EBIT | -124,357 | -96,015 | -99,274 | -72,254 |
Net Income | -124,697 | -96,015 | -85,981 | -72,188 |
Net Change In Cash | 0 | 0 | 8,094 | 13,620 |
Cost of Revenue | 36,011 | -33,865 | ||
Free Cash Flow | -100,666 | -95,695 | -100,992 | -79,045 |
Cash | 80,235 | 74,015 | 155,384 | 119,136 |
Basic Shares | 40,817 | 19,884 | 8,512 | 7,118 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.42 |
2025-03-31 | -$0.59 |
2024-12-31 | -$1 |
2024-09-30 | -$0.79 |
